Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-934-5 | CAS number: -
No carcinogenicity study on experimental animals is available for EUF. The compound is assumed to hydrolyse rapidly within the body. Effects for hydrolysis products in adequate dilutions are supposed. As the database for formaldehyde is comprehensive, no test for carcinogenicity is required. Assuming that the discussed in-vitro mutagenic effects of EUF are based on formaldehyde, no tumour formation is expected at non-irritant concentrations. No carcinogenic effects were reported for ethylene glycol or urea respectively.
Data on experimental animals: Data on long-term drinking water studies in rats revealed neither systemic carcinogenic effects nor sufficient evidence for local carcinogenic effects in the gastrointestinal tract. However, repeated oral studies consistently show that exposure to drinking water dose levels >50 mg/kg/day can damage epithelial tissue of the gastrointestinal tract, especially at dose levels >100-200 mg/kg/day.
Data on this endpoint showed local irritation but no carcinogenic effects. However, in initiation/promotion experiments formaldehyde significantly reduced the latency time for the development of tumours.
The available data on dermal exposure revealed local irritation but no carcinogenic effects.
In summary, the weight of evidence that formaldehyde induces systemic or local carcinogenic effects after oral or dermal exposure is insufficient.
There is clear evidence from chronic inhalation studies in rats that formaldehyde causes tumours in the nasal cavity. Even after subchronic exposure periods nasal tumours were induced. Limited data are available in mice; no tumours were detected in hamsters.
Data on carcinogenicity in humans: Numerous epidemiological studies are available in humans occupationally exposed via inhalation. The data suggested an increased risk of cancer at two tumour sites: the upper respiratory tract and the haematopoietic system. Some evidence for an association between nasopharyngeal tumours and formaldehyde exposure was reported in former cohort studies. Some epidemiological evidence for an association between formaldehyde exposure and leukaemia has been reported. However, in contrast to nasopharyngeal tumours, no plausible mechanism for the induction of leukaemia in humans is found.
The new legal harmonised classification of formaldehyde (Index No 605-001-00-5) is Carc. 1B and Muta. 2.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Close Do not show this message again